Carlson College of Veterinary Medicine

L. S. Young, Bermudez, L. E., and Inderlied, C. B., “Mycobacteria and AIDS: treatment, prevention and future prospects.”, Research in microbiology, vol. 143, no. 4, pp. 420-2, 1992.

L. E. Bermudez, Kolonoski, P., Young, L. S., and Inderlied, C. B., “Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.”, Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1844-8, 1994.

L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., and Young, L. S., “Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice.”, Antimicrobial agents and chemotherapy, vol. 38, no. 12, pp. 2717-21, 1994.

L. E. Bermudez, “Potential role of cytokines in disseminated mycobacterial infections.”, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 13 Suppl 2, pp. S29-33, 1994.

L. E. Bermudez, “Use of liposome preparation to treat mycobacterial infections.”, Immunobiology, vol. 191, no. 4-5, pp. 578-83, 1994.

E. M. Foley-Thomas, Whipple, D. L., Bermudez, L. E., and Barletta, R. G., “Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis.”, Microbiology (Reading, England), vol. 141 ( Pt 5), pp. 1173-81, 1995.

L. E. Bermudez and Kaplan, G., “Recombinant cytokines for controlling mycobacterial infections.”, Trends in microbiology, vol. 3, no. 1, pp. 22-7, 1995.

L. E. Bermudez, Kolonoski, P., and Young, L. S., “Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.”, Antimicrobial agents and chemotherapy, vol. 40, no. 4, pp. 1033-5, 1996.

N. Azouaou, Petrofsky, M., Young, L. S., and Bermudez, L. E., “Mycobacterium avium infection in mice is associated with time-related expression of Th1 and Th2 CD4+ T-lymphocyte response.”, Immunology, vol. 91, no. 3, pp. 414-20, 1997.

L. E. Bermudez, Petrofsky, M., and Stevens, P., “Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice.”, Immunology, vol. 94, no. 3, pp. 297-303, 1998.

L. E. Bermudez and Petrofsky, M., “Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells.”, Infection and immunity, vol. 67, no. 6, pp. 3108-11, 1999.

L. E. Bermudez, Goodman, J., and Petrofsky, M., “Role of complement receptors in uptake of Mycobacterium avium by macrophages in vivo: evidence from studies using CD18-deficient mice.”, Infection and immunity, vol. 67, no. 9, pp. 4912-6, 1999.

H. S. Wu, Kolonoski, P., Chang, Y. Y., and Bermudez, L. E., “Invasion of the brain and chronic central nervous system infection after systemic Mycobacterium avium complex infection in mice.”, Infection and immunity, vol. 68, no. 5, pp. 2979-84, 2000.

P. M. Roger and Bermudez, L. E., “Infection of mice with Mycobacterium avium primes CD8+ lymphocytes for apoptosis upon exposure to macrophages.”, Clinical immunology (Orlando, Fla.), vol. 99, no. 3, pp. 378-86, 2001.

J. A. McGarvey and Bermudez, L. E., “Phenotypic and genomic analyses of the Mycobacterium avium complex reveal differences in gastrointestinal invasion and genomic composition.”, Infection and immunity, vol. 69, no. 12, pp. 7242-9, 2001.

L. Broxmeyer, Sosnowska, D., Miltner, E., Chacon, O., Wagner, D., McGarvey, J., Barletta, R. G., and Bermudez, L. E., “Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens.”, The Journal of infectious diseases, vol. 186, no. 8, pp. 1155-60, 2002.

D. Wagner, Sangari, F. J., Kim, S., Petrofsky, M., and Bermudez, L. E., “Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo.”, Journal of leukocyte biology, vol. 71, no. 1, pp. 80-8, 2002.

J. McGarvey and Bermudez, L. E., “Pathogenesis of nontuberculous mycobacteria infections.”, Clinics in chest medicine, vol. 23, no. 3, pp. 569-83, 2002.

L. Danelishvili, Poort, M. J., and Bermudez, L. E., “Identification of Mycobacterium avium genes up-regulated in cultured macrophages and in mice.”, FEMS Microbiol Lett, vol. 239, no. 1, pp. 41-9, 2004.

L. Danelishvili, Young, L. S., and Bermudez, L. E., “In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium.”, Microbial drug resistance (Larchmont, N.Y.), vol. 12, no. 1, pp. 1-6, 2006.

L. Danelishvili, Young, L. S., and Bermudez, L. E., “In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium.”, Microb Drug Resist, vol. 12, no. 1, pp. 1-6, 2006.

A. E. Jolles, Etienne, R. S., and Olff, H., “Independent and competing disease risks: implications for host populations in variable environments.”, Am Nat, vol. 167, no. 5, pp. 745-57, 2006.

A. E. Jolles, Etienne, R. S., and Olff, H., “Independent and competing disease risks: implications for host populations in variable environments.”, The American naturalist, vol. 167, no. 5, pp. 745-57, 2006.

A. L. Michel, Bengis, R. G., Keet, D. F., Hofmeyr, M., de Klerk, L. M., Cross, P. C., Jolles, A. E., Cooper, D., Whyte, I. J., Buss, P., and Godfroid, J., “Wildlife tuberculosis in South African conservation areas: implications and challenges.”, Veterinary microbiology, vol. 112, no. 2-4, pp. 91-100, 2006.

A. L. Michel, Bengis, R. G., Keet, D. F., Hofmeyr, M., de Klerk, L. M., Cross, P. C., Jolles, A. E., Cooper, D., Whyte, I. J., Buss, P., and Godfroid, J., “Wildlife tuberculosis in South African conservation areas: implications and challenges.”, Vet Microbiol, vol. 112, no. 2-4, pp. 91-100, 2006.